116 related articles for article (PubMed ID: 2261733)
21. Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.
Hanrahan PS; Scrivens GA; Russell AS
Br J Rheumatol; 1989 Apr; 28(2):147-53. PubMed ID: 2706419
[TBL] [Abstract][Full Text] [Related]
22. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
23. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
[TBL] [Abstract][Full Text] [Related]
24. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
[TBL] [Abstract][Full Text] [Related]
25. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.
Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Lemmens AM
Ann Intern Med; 1991 Jun; 114(12):999-1004. PubMed ID: 2029111
[TBL] [Abstract][Full Text] [Related]
26. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
27. Calculating radiological progression in rheumatoid arthritis.
Scott DL; Dawes PT; Fowler PD; Shadforth MF
Clin Rheumatol; 1986 Dec; 5(4):445-9. PubMed ID: 3816092
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of destructive rheumatoid arthritis with methotrexate.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1997 Oct; 24(10):1881-9. PubMed ID: 9330927
[TBL] [Abstract][Full Text] [Related]
29. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin.
Weinblatt ME; Polisson R; Blotner SD; Sosman JL; Aliabadi P; Baker N; Weissman BN
Arthritis Rheum; 1993 May; 36(5):613-9. PubMed ID: 8489539
[TBL] [Abstract][Full Text] [Related]
30. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF
Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
[TBL] [Abstract][Full Text] [Related]
31. Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52.
Izumi K; Kaneko Y; Yasuoka H; Seta N; Kameda H; Kuwana M; Takeuchi T
Mod Rheumatol; 2015 Jan; 25(1):31-7. PubMed ID: 24684408
[TBL] [Abstract][Full Text] [Related]
32. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate.
Boiardi L; Macchioni P; Meliconi R; Pulsatelli L; Facchini A; Salvarani C
Clin Exp Rheumatol; 1999; 17(4):419-25. PubMed ID: 10464551
[TBL] [Abstract][Full Text] [Related]
33. Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
Burmester GR; Rigby WF; van Vollenhoven RF; Kay J; Rubbert-Roth A; Blanco R; Kadva A; Dimonaco S
Ann Rheum Dis; 2017 Jul; 76(7):1279-1284. PubMed ID: 28389552
[TBL] [Abstract][Full Text] [Related]
34. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.
López-Méndez A; Daniel WW; Reading JC; Ward JR; Alarcón GS
Arthritis Rheum; 1993 Oct; 36(10):1364-9. PubMed ID: 8216395
[TBL] [Abstract][Full Text] [Related]
35. Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline.
Alarcón GS; Bartolucci AA
J Rheumatol; 2000 Feb; 27(2):530-4. PubMed ID: 10685828
[TBL] [Abstract][Full Text] [Related]
36. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
van Vollenhoven RF; Geborek P; Forslind K; Albertsson K; Ernestam S; Petersson IF; Chatzidionysiou K; Bratt J;
Lancet; 2012 May; 379(9827):1712-20. PubMed ID: 22464340
[TBL] [Abstract][Full Text] [Related]
37. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW
Arthritis Rheum; 2007 May; 56(5):1424-32. PubMed ID: 17469099
[TBL] [Abstract][Full Text] [Related]
39. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.
Zhou YZ; Zhao LD; Chen H; Zhang Y; Wang DF; Huang LF; Lv QW; Liu B; Li Z; Wei W; Li H; Liao X; Liu H; Liu X; Jin H; Wang J; Fei YY; Wu QJ; Zhang W; Shi Q; Zheng WJ; Zhang FC; Tang FL; Lipsky PE; Zhang X
Arthritis Res Ther; 2018 Apr; 20(1):70. PubMed ID: 29636089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
